Yüklüyor......
Tardive dyskinesia with low dose amisulpride
In recent years, there has been an increasing trend to use amisulpride in the treatment of dysthymia and also as an adjunct treatment in patients with major depression. At low doses (50 mg), amisulpride preferentially blocks presynaptic auto receptors, enhances dopamine release, and therefore acts a...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medknow Publications & Media Pvt Ltd
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3574463/ https://ncbi.nlm.nih.gov/pubmed/23440033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5545.105523 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|